Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
56
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study

Yang Lyu1 Department of Intensive Care Unit, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer
,
Yang Yang2 Department of Anesthesia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer
,
Xin Li3 Department of Intensive Care Unit, Tianjin Medical University General Hospital, Tianjin
,
Min Peng3 Department of Intensive Care Unit, Tianjin Medical University General Hospital, Tianjin
,
Xin He2 Department of Anesthesia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer
,
Peng Zhang4 Department of Cardiothoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China
,
Shangwen Dong4 Department of Cardiothoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China
,
Wanhua Wang2 Department of Anesthesia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer
&
Donghao Wang1 Department of Intensive Care Unit, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for CancerCorrespondence[email protected]
 show all
Pages 31-37 | Published online: 21 Dec 2017

References

  • NseirSGraillesGSoury-LavergneAMinacoriFAlvesIDurocherAAccuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admissionClin Microbiol Infect201016790290819694760
  • Chinese Society of Respiratory Disease AssociationHospital-acquired pneumonia diagnosis and treatment guidelinesModern Practical Medicine200214160161
  • American thoracic societyInfectious Diseases Society of AmericaGuidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumoniaAm J Respir Crit Med20051714388416
  • LiJSongXYangTA systematic review of antibiotic prescription associated with upper respiratory tract infections in ChinaMedicine (Baltimore)20169519e358727175658
  • ZhouYFShiWPharmacokinetic/pharmacodynamic correlation of cefquinome against experimental catheter-associated biofilm infection due to Staphylococcus aureusFront Microbiol20166151326779167
  • LeeLSKiinzig-SchippersMNafzigerANComparison of 30 min and 3 h infusion regimens for imipenem/cilastatin and meropenem evaluated by Monte Carlo SimulationDiagn Microbiol Infect Dis201068325125820851549
  • LüYYanZWangDHDongWLYangYXiaRTreatment study of hospital acquired pneumonia by optimizing dosing regimen of piperacillin/tazobactam:prolonged versus. regular infusionZhonghua Wei Zhong Bing Ji Jiu Yi Xue2013258479483 Chinese24021044
  • LanganKMJacobJLiJPharmacokinetics of short versus extended infusion meropenem dosing in critically ill patients: a pilot studyCrit Care Resusc201416319019625161021
  • LeeGCLiouHYeeRQuanCFNeldnerKOutcomes of extended-nfusion piperacillin-tazobactam: a retrospective analysis of critically ill patientsClin Ther201234122297230023195962
  • LodiseTPJrLomaestroBDrusanoGLPiperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategyClin Infect Dis200744335736317205441
  • Cotrina-LuqueJGil-NavarroMVAcosta-GarcíaHContinuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosaInt J Clin Pharm2016381707926474861
  • Abdul-AzizMHLipmanJAkovaMDALI Study GroupIs prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohortJ Antimicrob Chemother201671119620726433783
  • Peres BotaDMelotCLopes FerreiraFNguyen BaVVincentJLThe multiple organ dysfunction score (MODS) versus the sequential organ failure assessment (SOFA) score in outcome predictionIntensive Care Med200228111619162412415450

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.